Início › Leucemia Linfocítica Crônica › Distrito de Columbia › Washington
Ensaios clínicos de Leucemia Linfocítica Crônica em Washington, DC
22 estudos para Leucemia Linfocítica Crônica estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecrutandoFase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · a 7 mi de distância
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
RecrutandoFase 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · a 7 mi de distância
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RecrutandoFase 3
- GC2202 Study Site 111, Bethesda · a 7 mi de distância
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecrutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
RecrutandoFase 3
- American Oncology Partners of Maryland Pa, Bethesda · a 7 mi de distância
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecrutandoFase 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RecrutandoFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · a 7 mi de distância
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RecrutandoFase 2
- Maryland Oncology Hematology, Silver Spring · a 7 mi de distância
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
RecrutandoFase 1 inicial
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RecrutandoFase 3
- American Oncology Partners of Maryland, PA, Bethesda · a 7 mi de distância
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
RecrutandoFase 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · a 7 mi de distância
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- National Institute of Health, Bethesda · a 7 mi de distância
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RecrutandoFase 2
- American Oncology Partners, PA, Bethesda · a 7 mi de distância
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RecrutandoFase 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · a 7 mi de distância
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · a 7 mi de distância
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RecrutandoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Ensaios de Leucemia Linfocítica Crônica em outras cidades
- Boston, MA31 estudos
- Columbus, OH28 estudos
- Durham, NC27 estudos
- Seattle, WA20 estudos
- Rochester, MN18 estudos
- New York City, NY18 estudos
- Houston, TX17 estudos
- Baldwin Park, CA16 estudos
- Milwaukee, WI15 estudos
- Chicago, IL14 estudos
- Cincinnati, OH14 estudos
- Nashville, TN13 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Câncer de Próstata38 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Câncer de Ovário23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.